phenanthroline

o-Phenanthroline (1,10-Phenanthroline) , a metal chelator, prevents the induction of chromosomal aberrations in streptozotocin-treated cells.o-Phenanthroline protects mammalian cells from hydrogen peroxide-induced gene mutation and morphological transformation.

5-Nitro-1,10-phenanthroline (5-NP) is a potent bactericidal agent that inhibits Clostridium difficile.

o-Phenanthroline monohydrate (1, 10-Phenanthroline monohydrate) is an inhibitor of metallopeptidases, inhibits zinc-dependent hydrolysis of Fa-Gly-Leu-NH2 by B. subtilis neutral protease and B. thermoproteolyticus thermolysin.

3,4,7,8-Tetramethyl-1,10-phenanthroline (TMPhen) is an organic molecule commonly utilized as a ligand or catalyst. It finds extensive use across various fields such as organometallic reactions, electrochemical detection, and organic optoelectronic devices. Its exceptional performance in fluorescence probes, biosensors, and photocatalytic reactions makes it widely applied in chemical and life sciences research.

Benzoquinoquinoxaline (BQQ) is a heterocyclic compound with aminoalkyl side chains containing benzo and quinoline ring structures.BQQ is triple-helix specific stabilizing compounds by preferentially binding to DNA triple junctions and inserting between the bases.Complexes of BQQ with 1,10-phenanthroline are able to bind specifically to and cleave double-stranded DNA at the cleave double-stranded DNA at sites that form triple structures.

Bathocuproine has shown significant potential for application as a hole-blocking layer in organic light-emitting diodes or as an electron buffer layer in organic photovoltaic cells.

Ascididemin can be regarded as a fused phenanthroline with quinoline.

Ph-Ph+ is a hemiprotonic compound derived from the dimerization of phenanthroline (ph), exhibiting notable antitumor, antibacterial, and antifungal properties [1].

BChE-IN-33 (compound 4r) is an aromatic amino naphthol derivative and an effective inhibitor of butyrylcholinesterase (BChE) with an IC50 of 14.78 µM. It also inhibits CYP2C19, CYP2C9, and CYP2D6. Exhibiting potent antioxidant activity, BChE-IN-33 has shown IC50 values of 150.48 μM, 2.56 μM, and 4.61 μM in DPPH, ABTS, and Ferric-phenanthroline assays, respectively. This compound demonstrates potential for research in Alzheimers disease.